COPYRIGHT © DIGITAL JOURNAL INC. Sitemaps: XML / News. Digital Journal is not responsible for the content of external sites. Read more about our external linking
United States, Nevada, Las Vegas, DelveInsight’s “Migraine – Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Migraine market share of the individual therapies, current and forecasted Migraine market size from 2019 to 2032 segmented by seven major markets. The report also offers current Migraine therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Migraine market.
Migraine Overview
Migraine is ranked globally as the seventh most disabling disease among all diseases (responsible for 2.9% of all years of life lost to disability/YLDs) and the leading cause of disability among all neurological disorders.
It includes severe throbbing recurring pain, usually on one side of the head, often accompanied by visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound, light, touch and smell, and tingling or numbness in the extremities or face; although symptoms usually include a severe throbbing recurring pain on one side of the head, yet in one-third of migraine attacks, both sides are found to be affected.
Migraine is classified by the nature of the attack and its frequency as chronic and episodic migraine. Episodic migraine is characterized by those with migraine who have 0–14 headache days per month, while chronic migraine is characterized by 15 or more headache days per month.
Migraine Epidemiological Insights
The total Migraine prevalent population in the 7MM was approximately 118,491,000 cases in 2021.
Migraine Treatment Market
Treatment can be acute or preventive. Acute treatment is initiated during an attack to alleviate pain and disability and to stop the progression of the attack. Preventive treatment is used when there exists a known headache trigger, such as exercise or sexual activity, and for patients who have limited time exposure to a trigger, such as high-altitude ascent or menstruation.
Promising Therapies in the Migraine Pipeline
Discover more about Migraine therapies in the pipeline @ Migraine Drugs
Leading Companies Working in the Migraine Market
To understand key companies related to the Migraine Market, get a snapshot of the Migraine Regulatory and Patent Analysis.
Scope of the Migraine Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan]
Key Migraine Companies: Impel NeuroPharma, and others
Key Migraine Pipeline Therapies: INP104, and others
Therapeutic Assessment: Migraine current marketed and emerging therapies
Migraine Market Dynamics: Migraine market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Migraine Market Access and Reimbursement
Table of Contents
Leading Reports by DelveInsight:
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Us
Kritika Rehani
info@delveinsight.com
+1(919)321-6187